Earnings History Data for Caribou Biosciences (CRBU) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Caribou Biosciences
Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors. Caribou Biosciences Inc. is based in BERKELEY, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-03-2024 | AH | CRBU | Caribou Biosciences | 654.00 | -0.39 | -0.22 | 0.00 | Caribou Bioscience GAAP EPS of -$0.39 in-line, revenue of $3.56M misses by $1.05M [3/11/2024 4:52 PM] |
5.04 | -2.18 (-30.26%) |
7.04 | -0.18 (-2.49%) |
3.44 - 8.59 | 6,279,482 | 1,290,000 | 2,353 | ||
| 07-11-2023 | AH | CRBU | Caribou Biosciences | 369.00 | -0.12 | -0.38 | 0.00 | Caribou Bioscience GAAP EPS of -$0.12 beats by $0.30, revenue of $23.66M beats by $20.54M [11/7/2023 5:23 PM] |
4.54 | -0.23 (-4.93%) |
4.88 | 0.11 (2.31%) |
3.44 - 10.67 | 1,650,956 | 2,310,000 | 1,318 | ||
| 09-03-2023 | PM | CRBU | Caribou Biosciences | 359.00 | -0.44 | -0.47 | 0.00 | Caribou Bioscience GAAP EPS of -$0.44 beats by $0.02, revenue of $3.7M beats by $0.63M [3/10/2023 3:33 AM] |
5.15 | -0.36 (-6.53%) |
6.15 | 0.64 (11.62%) |
4.89 - 13.19 | 752,227 | 350,000 | 275 | ||
| 09-08-2022 | AH | 4:05 PM ET (Aug 9) |
CRBU | Caribou Biosciences | 519.00 | -0.46 | -0.37 | 0.00 | Caribou Bioscience GAAP EPS of -$0.44 misses by $0.08, revenue of $4.19M beats by $1.33M [8/9/2022 5:19 PM] |
9.31 | 1.17 (14.37%) |
8.26 | 0.12 (1.47%) |
4.89 - 32.65 | 794,823 | 520,000 | 1,775 | |
| 09-05-2022 | AH | 4:00 PM ET (May 9) |
CRBU | Caribou Biosciences | 468.00 | -0.35 | -0.35 | 0.00 | Caribou Bioscience GAAP EPS of -$0.32 beats by $0.02, revenue of $2.66M misses by $0.54M [5/9/2022 5:17 PM] |
7.36 | 0.69 (10.42%) |
6.56 | -0.11 (-1.65%) |
6.54 - 32.65 | 369,383 | 525,723 | 1,847 | |
| 21-03-2022 | AH | 4:05 PM ET (Mar 21) |
CRBU | Caribou Biosciences | 571.00 | -0.34 | -0.34 | 0.00 | Caribou Bioscience GAAP EPS of -$0.31 beats by $0.05, revenue of $2.56M misses by $0.87M [3/21/2022 5:05 PM] |
10.02 | 0.87 (9.51%) |
9.15 | 0.0 (0.00%) |
8.37 - 32.65 | 605,688 | 614,315 | 10,568 | |
| 09-11-2021 | AH | CRBU | Caribou Biosciences | 1,346 | -0.46 | -0.01 | 0.00 | Caribou Bioscience EPS misses by $0.40, beats on revenue [11/9/2021 4:55 PM] |
20.77 | -0.39 (-1.84%) |
22.40 | 1.24 (5.86%) |
15.00 - 32.65 | 217,283 | 290,000 | 224 | ||
|
||||||||||||||||||